## BRO: Brown & Brown, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.1% below STRENGTH zone (4.0-10.0%); PEG 4.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. Howden US blames Brown & Brown culture for mass employee exits**
- Source: Beinsure | 20251230T160753 | Bearish | Relevance: 100%
- Howden US refutes allegations of trade-secret theft and unfair competition from Brown & Brown, claiming that mass employee departures were due to Brown & Brown's poor corporate culture, low compensation, and management issues. Howden argues that employees resigned voluntarily and were simply offered jobs, emphasizing that client movement follows brokers. The dispute highlights intense competition and recruitment practices within the insurance brokerage industry, amidst reports of Howden hiring over 200 Brown & Brown employees.

**2. Howden US Tells Judge Brown & Brown Employees Fled Due to ‘Mistreatment’**
- Source: Insurance Journal | 20251230T060747 | Bearish | Relevance: 100%
- Howden US has responded to a lawsuit filed by Brown & Brown, claiming that employees left Brown & Brown due to "mistreatment" and "terrible management" rather than a "pirate raid." Howden US asserts that the employees were unhappy with their former employer's corporate culture, compensation, and reporting, and denies allegations of trade secret theft or unfair competition. Howden US also highlights that Jim Hays, a former Brown & Brown executive now with Howden Group Holdings, is a plaintiff in the case despite being accused of complicity in the alleged poaching, and claims Hays' financial interest in Brown & Brown makes the allegations against him illogical.

**3. Who Owns Brown & Brown? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251228T130737 | Neutral | Relevance: 100%
- Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage with a market value of approximately $27.6 billion. The article details the top institutional shareholders, including The Vanguard Group, J. Hyatt Brown, and Capital World Investors, noting recent changes in their holdings. It also highlights significant moves by hedge funds like Winton Group and AQR Capital Management, alongside recent insider trades, providing insight into current perceptions of the stock's valuation and growth prospects.

**4. Westbourne Investment Advisors Inc. Takes $5.62 Million Position in Brown & Brown, Inc. $BRO**
- Source: MarketBeat | 20251230T140507 | Somewhat-Bullish | Relevance: 100%
- Westbourne Investment Advisors Inc. has acquired a new stake of 59,964 shares in Brown & Brown, Inc. ($BRO), valued at approximately $5.62 million, making it their 23rd largest holding. Major institutions hold about 71.01% of the stock, with Vanguard Group, Norges Bank, and Boston Partners having significant positions. Analysts currently have a "Hold" rating with an average target price of $99.80, following Brown & Brown's strong Q3 earnings and increased dividend.

**5. Brown & Brown Inc. Stock Weathers Volatility as Insurer Quietly Outperforms the Market**
- Source: AD HOC NEWS | 20251229T213525 | Bullish | Relevance: 100%
- Brown & Brown Inc. (NYSE: BRO) has demonstrated consistent outperformance against the broader market, driven by disciplined growth, expanding margins, and strategic acquisitions. Despite recent minor pullbacks, the insurance broker has delivered a 28% one-year gain, supported by robust organic revenue growth and continued M&A activity. Wall Street remains constructive on the stock, viewing it as a reliable compounder with further upside potential, while acknowledging its expanded valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | BMO Capital | $88 | $90 | -2% |
| 2025-12-18 | JP Morgan | $91 | $0 | 0% |
| 2025-12-16 | Mizuho | $89 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | BMO Capital | down | Market Perform |
| 2025-12-18 | JP Morgan | init | Neutral |
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+4.8%)
- Blackrock Inc.: 6.1% (+2.2%)
- Capital World Invest: 5.1% (+81.1%)
- Principal Financial : 4.5% (+13.4%)
- State Street Corpora: 3.8% (+5.3%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Long-term trend broken: trading 19.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +1.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.41 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Revenue growth strong at 23% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 0.81 |
| 52W Range | $76.17 - $125.68 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.41 |
| Forward P/E | 17.2 |
| Current P/E | 18.9 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.1% to 0.1% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 48. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.10% (CS: 46) | Neutral |
| RSI_14 | 47.8 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 0.810x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $80.22
- **Stop Loss:** $77.28 (3.7% risk)
- **Target:** $83.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 280
- **Position Value:** $22,461.60
- **Portfolio %:** 22.46%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-26 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $1.05 | +12.9% |
| 2025Q2 | $0.99 | $1.03 | +4.6% |
| 2025Q1 | $1.30 | $1.29 | -0.5% |
| 2024Q4 | $0.77 | $0.86 | +12.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*